Zomedica · 1 week ago
Sales Account Manager, Utah / Nevada
Zomedica is an innovative company in the animal health industry, seeking a Sales Account Manager to drive sales and foster relationships with veterinary professionals. The role involves selling cutting-edge diagnostic and therapeutic solutions while contributing to the company's growth and success.
PharmaceuticalVeterinary
Responsibilities
Build long-term relationships with customers and grow account revenue through comprehensive and complementary product offerings
Sell innovative diagnostic, therapeutic, monitoring, and imaging technologies that enhance the quality of care for pets and improve clinic workflow and profitability
Collaborate with regional Area Sales Director, Professional Services Veterinarian, Capital Equipment Specialist, and Inside Sales Representative to achieve sales goals
Utilize a robust marketing engine to deliver leads and increase brand awareness
Qualification
Required
Bachelor's Degree in a scientific or related discipline, or an equivalent combination of related education and/or experience
3+ years of relevant sales experience that translates well to the sale of capital equipment / medical device in the animal health industry
Strong closing skills, with a proven track record of sales (ideally capital sales) and customer service excellence
Demonstrated ability to build strong customer relationships
Excellent communication and interpersonal skills, with ability to work effectively in a collaborative sales environment
Ability to travel to all call points within an assigned territory
Strong computer skills, with experience utilizing a CRM management database; salesforce.com preferred
Benefits
Excellent compensation and incentives
Medical insurance
Employer-paid dental / vision / disability / life insurance
401k plan with a Company match
Generous PTO
Paid holidays
A collaborative work environment
Great growth potential
Company
Zomedica
Zomedica is a veterinary pharmaceutical company.
Funding
Current Stage
Public CompanyTotal Funding
$254.45M2021-02-08Post Ipo Equity· $173.5M
2020-07-01Post Ipo Equity· $50M
2020-02-12Post Ipo Equity· $2.5M
Recent News
Company data provided by crunchbase